• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number 37602
Device Problems Break (1069); High impedance (1291); Unintended Collision (1429)
Patient Problem Therapeutic Effects, Unexpected (2099)
Event Date 08/26/2020
Event Type  Injury  
Manufacturer Narrative
The main component of the system and other applicable components are: product id: 3389, lot#: unknown, product type: lead.Product id: 3389, serial/lot #: unknown.Date of event: please note that this date is based off of the date of publication of the article as the event dates were not provided in the published literature.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Subthalamic nucleus deep brain stimulation in post-infarct dystonia.Kantharuby tambirajoo, luciano furlanetti, michael samuel, keyoumars ashkan.Doi: 10.1159/000509317 abstract: dystonia secondary to cerebral infarcts presents months to years after the initial insult, is usually unilateral and causes significant morbidity.Deep brain stimulation (dbs) of the globus pallidus internus (gpi) is established as the most frequent target in the management of the dystonic symptoms.We report our experience with subthalamic nucleus (stn)dbs in 3 patients with post-infarct dystonia, in whom gpi dbs was not confidently possible due to the presence of striatal infarcts.Two patients had unilateral stn dbs implantation, whereas the third patient had bilateral stn dbs implantation for bilateral dystonic symptoms.Prospectively collected preoperative and postoperative functional assessment data including imaging, medication and neuropsychology evaluations were analyzed with regard to symptom improvement.Median follow-up period was 38.3 months (range 26¿43 months).All patients had clinically valuable improvements in dystonic symptoms and pain control despite variable improvements in the burke-fahn-marsden dystonia rating scores.In our series, we have demonstrated that stn dbs could be an alternative in the management of post-infarct dystonia in patients with abnormal striatal anatomy which precludes gpi dbs.A multidisciplinary teambased approach is essential for patient selection and management.Reported events: it was reported that a patient hit their head on a metal bench 9 months after surgery and rapidly lost all stimulation benefit, reverting to their preoperative state.Interrogation of their system revealed high impedances, although ct and x-ray imaging didn't reveal any obviopus lead fractures.Despite attempts at multiple re-programming sessions the lost benefit wasn't regained.Subsequent surgical revision later revealed a lead fracture.Post-revision bipolar stimulation proved most efficacious resulting in improved ambulation and 60% improvement in foot and hand dystonia with minimal spasms.It was not possible to ascertain any additional specific device information from the article or to match the reported event with any previously reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central ave ne
minneapolis MN 55432
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key10712159
MDR Text Key216605158
Report Number2182207-2020-01115
Device Sequence Number1
Product Code MHY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P960009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other
Type of Report Initial
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number37602
Device Catalogue Number37602
Was Device Available for Evaluation? No
Date Manufacturer Received09/25/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age21 YR
-
-